Brief: Zynerba Pharmaceuticals Presents New Data In Two Posters At 2020 Annual Meeting Of The American Epilepsy Society
04/12/2020 17:32
Dec 4 (Reuters) - Zynerba Pharmaceuticals Inc ZYNE.O :
* ZYNERBA PHARMACEUTICALS PRESENTS NEW DATA IN TWO POSTERS
AT THE
2020 ANNUAL MEETING OF THE AMERICAN EPILEPSY SOCIETY (AES)
* ZYNERBA PHARMACEUTICALS INC - NEW EFFICACY DATA DESCRIBE
STRONG
EVIDENCE OF SEIZURE REDUCTION OVER 12 MONTHS OF TREATMENT
* ZYNERBA PHARMACEUTICALS - ZYGEL IMPROVES PROFOUND SLEEP
DISTURBANCE OFTEN EXPERIENCED BY DEE PATIENTS ENROLLED IN
BELIEVE TRIAL
Source text for Eikon: urn:newsml:reuters.com:*:nGNX9FB8CG
Further company coverage: ZYNE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary